Testing effectiveness (Phase 2)Study completedNCT00530114
What this trial is testing
Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
Who this might be right for
End Stage Renal DiseaseChronic Kidney DiseaseHyperphosphatemic+1 more
Amgen 167